| Financial Year |
March 31 2023 |
| Monetary Funds |
643,302,642.37 |
| Held-for-trading Financial Assets |
844,010,857.00 |
| Notes Receivable |
8,044,385.82 |
| Accounts Receivable |
806,372,485.38 |
| Advances to Suppliers |
1,100,864.29 |
| Other Receivables |
112,364,887.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
570,266,585.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,687,510.22 |
| Total Current Assets |
3,015,952,107.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
82,885,393.18 |
| Investment Properties |
175,702,322.55 |
| Fixed Assetes |
265,582,069.08 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
165,195,925.54 |
| R&D expenses |
143,061,151.23 |
| Goodwill |
445,407,170.79 |
| Long-Term Deferred and Prepaid Expenses |
5,592,841.47 |
| Deferred Income Tax Assets |
69,541,148.27 |
| Other Non-Current Assets |
140,716.98 |
| Sub-Total of Non-Current Assets |
1,386,899,293.94 |
| Total Assets |
4,402,851,401.71 |
| Short-Term Loans |
14,108,148.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
333,290,271.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
64,402,110.10 |
| Taxes Payable |
23,096,472.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,846,899.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,080,328.18 |
| Other Current Liabilities |
40,448,429.26 |
| Sub-Total of Current Liabilities |
1,517,701,906.47 |
| Long-term Loans |
1,910,983.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,309,217.95 |
| Total Liabilities |
1,526,011,124.42 |
| Paid-In Capital(Or Share Stock) |
492,766,617.00 |
| Capital Surplus |
1,662,404,453.24 |
| Surplus Reserve |
91,463,799.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
630,643,629.23 |
| Minority Stockholder's Interest |
1,720,042.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,875,120,234.52 |
| Owner's Equity（Stockholder's Equity） |
2,876,840,277.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,402,851,401.71 |
